Kailera Therapeutics, Inc. (KLRA)
NASDAQ: KLRA · Real-Time Price · USD
17.50
-0.82 (-4.48%)
Aug 20, 2026, 2:26 PM EDT - Market open

Kailera Therapeutics Statistics

Total Valuation

KLRA has a market cap or net worth of $2.27 billion. The enterprise value is $1.11 billion.

Market Cap2.27B
Enterprise Value 1.11B

Important Dates

The last earnings date was Wednesday, August 12, 2026, after market close.

Earnings Date Aug 12, 2026
Ex-Dividend Date n/a

Share Statistics

KLRA has 129.64 million shares outstanding.

Current Share Class 129.64M
Shares Outstanding 129.64M
Shares Change (YoY) n/a
Shares Change (QoQ) +473,018.01%
Owned by Insiders (%) 0.03%
Owned by Institutions (%) 43.07%
Float 58.48M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 2.12
P/TBV Ratio 2.12
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 11.11, with a Debt / Equity ratio of 0.01.

Current Ratio 11.11
Quick Ratio 11.03
Debt / Equity 0.01
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) -27.78%
Weighted Average Cost of Capital (WACC) n/a
Revenue Per Employee n/a
Profits Per Employee -$2.02M
Employee Count 145
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) n/a
52-Week Price Change n/a
50-Day Moving Average 19.25
200-Day Moving Average n/a
Relative Strength Index (RSI) 41.89
Average Volume (20 Days) 533,643

Short Selling Information

The latest short interest is 6.63 million, so 5.11% of the outstanding shares have been sold short.

Short Interest 6.63M
Short Previous Month 6.41M
Short % of Shares Out 5.11%
Short % of Float 11.33%
Short Ratio (days to cover) 10.88

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -313.27M
Pretax Income -292.20M
Net Income -292.20M
EBITDA -312.88M
EBIT -313.27M
Earnings Per Share (EPS) -$2.25
Full Income Statement

Balance Sheet

The company has $916.74 million in cash and $10.22 million in debt, with a net cash position of $1.16 billion or $8.96 per share.

Cash & Cash Equivalents 916.74M
Total Debt 10.22M
Net Cash 1.16B
Net Cash Per Share $8.96
Equity (Book Value) 1.12B
Book Value Per Share 8.63
Working Capital 845.52M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$221.62 million and capital expenditures -$2.09 million, giving a free cash flow of -$223.70 million.

Operating Cash Flow -221.62M
Capital Expenditures -2.09M
Depreciation & Amortization 387,000
Net Borrowing n/a
Free Cash Flow -223.70M
FCF Per Share -$1.73
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

KLRA does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield -12.30%
FCF Yield -9.42%

Analyst Forecast

The average price target for KLRA is $42.40, which is 142.29% higher than the current price. The consensus rating is "Strong Buy".

Price Target $42.40
Price Target Difference 142.29%
Analyst Consensus Strong Buy
Analyst Count 6
Revenue Growth Forecast (3Y) n/a
EPS Growth Forecast (3Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1